CTGov Compliance My Organizations

Compliance Rate

Compliance Rate 0.0%

Compliant submissions 0

Incompliant submissions 1

Total trials 1

My Organizations' Clinical Trials

Showing 25 of 361 entries

View as:

Canadian Study of Trandolapril on Blood Pressure in Hypertensive Patients

Phase: N/A Priority: Normal

NCT ID: NCT01078584 Org: User:

Start: 12/31/08 End: 09/30/11 Due: 09/30/12

Study of the Safety and Efficacy of Cefdinir and Levofloxacin for the Treatment of Subjects With Acute Bacterial Sinusitis

Phase: N/A Priority: Normal

NCT ID: NCT00645073 Org: User:

Start: 11/30/03 End: - Due: -

Study of Two Dosing Schedules of Adalimumab in Subjects With Moderate to Severe Chronic Plaque Psoriasis

Phase: N/A Priority: Normal

NCT ID: NCT00645905 Org: User:

Start: 06/30/03 End: - Due: -

An Evaluation of the Safety and Efficacy of ABT-925 in Subjects With Acute Exacerbation of Schizophrenia

Phase: N/A Priority: Normal

NCT ID: NCT00412620 Org: User:

Start: 12/31/06 End: 10/31/07 Due: 10/31/08

Paricalcitol Injection Phase II Trial

Phase: N/A Priority: Normal

NCT ID: NCT00646932 Org: User:

Start: 11/30/05 End: - Due: -

Estimate the Behavior of Chinese Anesthesiologists Practicing General Anesthesia With Sevoflurane

Phase: N/A Priority: Normal

NCT ID: NCT01199471 Org: User:

Start: 09/30/10 End: 11/30/10 Due: 11/30/11

Study to Evaluate the Long-Term Safety and Efficacy of ABT-335, in Combination With Three Different Statins in Subjects With Mixed Dyslipidemia.

Phase: N/A Priority: Normal

NCT ID: NCT00300430 Org: User:

Start: 09/30/06 End: - Due: -

Study to Investigate the Effects of Different Doses of S-adenosyl-L-methionine (SAMe) in Subjects With Nonalcoholic Fatty Liver Disease and Non-treated Matched Healthy Volunteers as Control Group

Phase: N/A Priority: Normal

NCT ID: NCT01754714 Org: User:

Start: 12/31/12 End: 09/30/14 Due: 09/30/15

A Phase 1 Study of the Safety, Tolerability and Pharmacokinetics of ABT-126 in Subjects With Alzheimer's Disease

Phase: N/A Priority: Normal

NCT ID: NCT01482845 Org: User:

Start: 11/30/11 End: 03/31/12 Due: 03/31/13

Study in Healthy Adults to Evaluate Pharmacokinetics, Safety and Tolerability of ABT-450 With Ritonavir

Phase: N/A Priority: Normal

NCT ID: NCT00931281 Org: User:

Start: 06/30/09 End: - Due: -

A Study Comparing the Analgesic Activity of Extended Release Hydrocodone/Acetaminophen (Vicodin® CR) and Placebo in Subjects With Pain Following Bunionectomy Surgery

Phase: N/A Priority: Normal

NCT ID: NCT00404391 Org: User:

Start: 10/31/03 End: 03/31/04 Due: 03/31/05

Evaluate Safety and Efficacy of ABT-335 in Combination With Rosuvastatin Calcium in Subjects With Multiple Abnormal Lipid Levels in the Blood

Phase: N/A Priority: Normal

NCT ID: NCT00300482 Org: User:

Start: 03/31/06 End: - Due: -

Early Access Program of the Safety of Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Active Rheumatoid Arthritis

Phase: N/A Priority: Normal

NCT ID: NCT00650026 Org: User:

Start: - End: - Due: -

A Study for Treatment of Partial Seizures in Children

Phase: N/A Priority: Normal

NCT ID: NCT00102713 Org: User:

Start: 02/28/05 End: - Due: -

Safety and Efficacy of Atrasentan in Men With Hormone Naive Prostate Cancer Exhibiting Early Signs of Biochemical Failure

Phase: N/A Priority: Normal

NCT ID: NCT00038662 Org: User:

Start: 05/31/02 End: - Due: -

Lopinavir/Ritonavir in Combination With Saquinavir Mesylate or Lamivudine/Zidovudine to Explore Metabolic Toxicities in Antiretroviral HIV-Infected Subjects

Phase: N/A Priority: Normal

NCT ID: NCT00043953 Org: User:

Start: 08/31/02 End: - Due: -

Assessment of the Effect of Adalimumab on Response to Influenza Virus and Pneumococcal Vaccines in Subjects With Rheumatoid Arthritis

Phase: N/A Priority: Normal

NCT ID: NCT00649922 Org: User:

Start: 10/31/03 End: 02/28/05 Due: 02/28/06

A Study of Single Dose of ABT-333 in Healthy Male Adults

Phase: N/A Priority: Normal

NCT ID: NCT00919490 Org: User:

Start: 06/30/09 End: - Due: -

Russian Study of the Efficacy and Safety of Tarka in Patients With Hypertension

Phase: N/A Priority: Normal

NCT ID: NCT00235001 Org: User:

Start: 06/30/04 End: - Due: -

Assess the Oral Bioavailability of a New ABT-263 Formulation in Healthy Female Subjects

Phase: N/A Priority: Normal

NCT ID: NCT01053520 Org: User:

Start: 10/31/09 End: 01/31/10 Due: 01/31/11

Post Marketing Surveillance of Safety and Efficacy for Cholib in Korean Patients Under the "New Drug Re-examination".

Phase: N/A Priority: Normal

NCT ID: NCT02489331 Org: User:

Start: 07/31/15 End: 11/10/20 Due: 11/10/21

A Trial of PDL192 in Subjects With Advanced Solid Tumors

Phase: N/A Priority: Normal

NCT ID: NCT00738764 Org: User:

Start: 07/31/08 End: 10/31/11 Due: 10/31/12

Effectiveness of Synagis (Palivizumab) Immunoprophylaxis in Preterm Infants With High Risk of Severe Respiratory Syncytial Virus (RSV) Infection

Phase: N/A Priority: Normal

NCT ID: NCT01107535 Org: User:

Start: 09/30/07 End: 02/28/11 Due: 02/28/12

Controlled Study of Humira in Subjects With Chronic Plaque Psoriasis of the Hands and/or Feet

Phase: N/A Priority: Normal

NCT ID: NCT00735787 Org: User:

Start: 08/31/08 End: 09/30/09 Due: 09/30/10

Open Label Study to Assess Efficacy and Safety of the Fully Human Anti-TNF-Alpha Monoclonal Antibody Adalimumab

Phase: N/A Priority: Normal

NCT ID: NCT00650390 Org: User:

Start: - End: - Due: -

Title	NCT ID	Organization	User	Status	Start Date	End Date	Reporting Due Date	Last Checked	User Role	Org Created
Canadian Study of Trandolapril on Blood Pressure in Hypertensive Patients	NCT01078584	Abbott	user2@example.com	None	2008-12-31	2011-09-30	2012-09-30	-	-	2025-07-14
Study of the Safety and Efficacy of Cefdinir and Levofloxacin for the Treatment of Subjects With Acute Bacterial Sinusitis	NCT00645073	Abbott	user2@example.com	None	2003-11-30	-	-	-	-	2025-07-14
Study of Two Dosing Schedules of Adalimumab in Subjects With Moderate to Severe Chronic Plaque Psoriasis	NCT00645905	Abbott	user2@example.com	None	2003-06-30	-	-	-	-	2025-07-14
An Evaluation of the Safety and Efficacy of ABT-925 in Subjects With Acute Exacerbation of Schizophrenia	NCT00412620	Abbott	user2@example.com	None	2006-12-31	2007-10-31	2008-10-31	-	-	2025-07-14
Paricalcitol Injection Phase II Trial	NCT00646932	Abbott	user2@example.com	None	2005-11-30	-	-	-	-	2025-07-14
Estimate the Behavior of Chinese Anesthesiologists Practicing General Anesthesia With Sevoflurane	NCT01199471	Abbott	user2@example.com	None	2010-09-30	2010-11-30	2011-11-30	-	-	2025-07-14
Study to Evaluate the Long-Term Safety and Efficacy of ABT-335, in Combination With Three Different Statins in Subjects With Mixed Dyslipidemia.	NCT00300430	Abbott	user2@example.com	None	2006-09-30	-	-	-	-	2025-07-14
Study to Investigate the Effects of Different Doses of S-adenosyl-L-methionine (SAMe) in Subjects With Nonalcoholic Fatty Liver Disease and Non-treated Matched Healthy Volunteers as Control Group	NCT01754714	Abbott	user2@example.com	None	2012-12-31	2014-09-30	2015-09-30	-	-	2025-07-14
A Phase 1 Study of the Safety, Tolerability and Pharmacokinetics of ABT-126 in Subjects With Alzheimer's Disease	NCT01482845	Abbott	user2@example.com	None	2011-11-30	2012-03-31	2013-03-31	-	-	2025-07-14
Study in Healthy Adults to Evaluate Pharmacokinetics, Safety and Tolerability of ABT-450 With Ritonavir	NCT00931281	Abbott	user2@example.com	None	2009-06-30	-	-	-	-	2025-07-14
A Study Comparing the Analgesic Activity of Extended Release Hydrocodone/Acetaminophen (Vicodin® CR) and Placebo in Subjects With Pain Following Bunionectomy Surgery	NCT00404391	Abbott	user2@example.com	None	2003-10-31	2004-03-31	2005-03-31	-	-	2025-07-14
Evaluate Safety and Efficacy of ABT-335 in Combination With Rosuvastatin Calcium in Subjects With Multiple Abnormal Lipid Levels in the Blood	NCT00300482	Abbott	user2@example.com	None	2006-03-31	-	-	-	-	2025-07-14
Early Access Program of the Safety of Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Active Rheumatoid Arthritis	NCT00650026	Abbott	user2@example.com	None	-	-	-	-	-	2025-07-14
A Study for Treatment of Partial Seizures in Children	NCT00102713	Abbott	user2@example.com	None	2005-02-28	-	-	-	-	2025-07-14
Safety and Efficacy of Atrasentan in Men With Hormone Naive Prostate Cancer Exhibiting Early Signs of Biochemical Failure	NCT00038662	Abbott	user2@example.com	None	2002-05-31	-	-	-	-	2025-07-14
Lopinavir/Ritonavir in Combination With Saquinavir Mesylate or Lamivudine/Zidovudine to Explore Metabolic Toxicities in Antiretroviral HIV-Infected Subjects	NCT00043953	Abbott	user2@example.com	None	2002-08-31	-	-	-	-	2025-07-14
Assessment of the Effect of Adalimumab on Response to Influenza Virus and Pneumococcal Vaccines in Subjects With Rheumatoid Arthritis	NCT00649922	Abbott	user2@example.com	None	2003-10-31	2005-02-28	2006-02-28	-	-	2025-07-14
A Study of Single Dose of ABT-333 in Healthy Male Adults	NCT00919490	Abbott	user2@example.com	None	2009-06-30	-	-	-	-	2025-07-14
Russian Study of the Efficacy and Safety of Tarka in Patients With Hypertension	NCT00235001	Abbott	user2@example.com	None	2004-06-30	-	-	-	-	2025-07-14
Assess the Oral Bioavailability of a New ABT-263 Formulation in Healthy Female Subjects	NCT01053520	Abbott	user2@example.com	None	2009-10-31	2010-01-31	2011-01-31	-	-	2025-07-14
Post Marketing Surveillance of Safety and Efficacy for Cholib in Korean Patients Under the "New Drug Re-examination".	NCT02489331	Abbott	user2@example.com	None	2015-07-31	2020-11-10	2021-11-10	-	-	2025-07-14
A Trial of PDL192 in Subjects With Advanced Solid Tumors	NCT00738764	Abbott	user2@example.com	None	2008-07-31	2011-10-31	2012-10-31	-	-	2025-07-14
Effectiveness of Synagis (Palivizumab) Immunoprophylaxis in Preterm Infants With High Risk of Severe Respiratory Syncytial Virus (RSV) Infection	NCT01107535	Abbott	user2@example.com	None	2007-09-30	2011-02-28	2012-02-28	-	-	2025-07-14
Controlled Study of Humira in Subjects With Chronic Plaque Psoriasis of the Hands and/or Feet	NCT00735787	Abbott	user2@example.com	None	2008-08-31	2009-09-30	2010-09-30	-	-	2025-07-14
Open Label Study to Assess Efficacy and Safety of the Fully Human Anti-TNF-Alpha Monoclonal Antibody Adalimumab	NCT00650390	Abbott	user2@example.com	None	-	-	-	-	-	2025-07-14

Compliance Rate

My Organizations' Clinical Trials

Appearance